Clinical efficacy of casirivimab and imdevimab in preventing COVID-19 in the Omicron BA.5 subvariant epidemic: a retrospective study
Ohtani et al., Journal of Pharmaceutical Health Care and Sciences, doi:10.1186/s40780-025-00501-x (preprint 5/13/2025)
https://c19early.org/ohtani.html